Mercury Pharma sold to Cinven three years after P2P
HgCapital has sold its interest in Mercury Pharma for a value of £465 million, marking its fifteenth portfolio company realisation in three years.
News
HgCapital has sold its interest in Mercury Pharma for a value of £465 million, marking its fifteenth portfolio company realisation in three years.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software